Skip to main content

Table 2 Variation in the RAD51 gene

From: Variation in the RAD51 gene and familial breast cancer

Gene region

PCR fragment

Nucleotide change

Amino acid change

Number (%) of heterozygous familiesa

Number (%) of heterozygous controls

Exon 1 (5' UTR)

1

c.-135G>C

-

3/28 (10.7%)

N/D

Exon 1 (5' UTR)

1

c.-172G>T

-

16/33 (48.5%)

N/D

Intron 2

2

c.97+110A>G

-

3/46 (6.5%)

16/93 (17.2%)

Intron 3

4

c.226-33T>G

-

11/46 (23.9%)

23/93 (24.7%)

Intron 3

4

c.226-70T>A

-

20/46 (43.5%)

43/93 (46.2%)

Intron 3

4

c.226-72delA

-

2/46 (4.3%)

8/93 (8.6%)

Intron 3

4

c.226-33T>G and c.226-70T>A

-

4/46 (8.7%)

8/93 (8.6%)

Intron 3

4

c.226-33T>G and c.226-72delA

-

1/46 (2.1%)

0/93 (0%)

Intron 3

4

c.226-70T>A and c.226-72delA

-

1/46 (2.1%)

6/93 (6.5%)

Intron 4

5

c.344-36T>G

-

3/46 (6.5%)

16/93 (17.2%)

Exon 6

6

c.449G>A

p.R150Qb

0/46 (0%), 0/66 (0%)

N/D

Intron 7

7

c.644+57G>T

-

1/46 (2.2%)

0/93 (0%)

Intron 8

9

c.775-41G>C

-

1/46 (2.2%)

N/D

Exon 10 (3' UTR)

10b

c.1020*+502T>G

-

19/46 (41.3%)

N/D

Exon 10 (3' UTR)

10c

c.1020*+718G>A

-

18/44 (40.9%)

N/D

Exon 10 (3' UTR)

10d

c.1020*+927T>C

-

17/42 (40.4%)

N/D

  1. UTR, untranslated region; N/D, not determined aValues expressed as the number of heterozygous families because all related individuals shared the same genotype. bReported in Kato and colleagues [22].